Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of the musculature (HP:0003011)help
Parent Node:
expand
Abnormal skeletal muscle morphology (HP:0011805)help
..Starting node
..expand
Abnormal muscle fiber morphology (HP:0004303)help
Term ID: 4303
Name: Abnormal muscle fiber morphology
Synonym: Abnormal muscle fibre morphology; Abnormal skeletal muscle fiber morphology; Abnormal skeletal muscle fibre morphology; Abnormality of muscle fibers; Abnormality of muscle fibres
Definition: Any abnormality of the skeletal muscle cell. Muscle fibers are subdivided into two types. Type I fibers are fatigue-resistant and rich in oxidative enzymes (they stain light with the myosin ATPase reaction), and type II fibers are fast-contracting, fatigue-prone, and rich in glycolytic enzymes (these fibers stain darkly). Normal muscle tissue has a random distribution of type I and type II fibers.
Comments:
Reference: HP:0004303
Genes and Diseases:
 
       Child Nodes:
........expandRagged-red muscle fibers (HP:0003200) help
........expandMuscle fiber splitting (HP:0003555) help
........expandCentrally nucleated skeletal muscle fibers (HP:0003687) help
........expandMuscle fiber necrosis (HP:0003713) help
........expandAutophagic vacuoles (HP:0003736) help
........expandDeposits immunoreactive to beta-amyloid protein (HP:0003791) help
........expandType 1 muscle fiber predominance (HP:0003803) help
........expandRimmed vacuoles (HP:0003805) help
........expandIncreased muscle lipid content (HP:0009058) help
................... HP:0012240 Increased intramyocellular lipid droplets
........expandType 2 muscle fiber predominance (HP:0010602) help
........expandAbnormality of skeletal muscle fiber size (HP:0012084) help
................... HP:0003557 Increased variability in muscle fiber diameter
................... HP:0003755 Type 1 fibers relatively smaller than type 2 fibers
........expandAbnormal muscle glycogen content (HP:0012269) help
................... HP:0009051 Increased muscle glycogen content
................... HP:0012270 Decreased muscle glycogen content
........expandAbnormal muscle fiber protein expression (HP:0030089) help
................... HP:0030090 Abnormal muscle fiber merosin expression
................... HP:0030093 Abnormal muscle fiber laminin beta 1
................... HP:0030095 Reduced muscle collagen VI
................... HP:0030096 Abnormal muscle fiber dystrophin expression
................... HP:0030100 Abnormal muscle fiber alpha sarcoglycan
................... HP:0030103 Abnormal muscle fiber beta sarcoglycan
................... HP:0030104 Abnormal muscle fiber gamma sarcoglycan
................... HP:0030105 Abnormal muscle fiber delta sarcoglycan
................... HP:0030112 Abnormal muscle fiber alpha dystroglycan
................... HP:0030113 Abnormal muscle fiber dysferlin
................... HP:0030116 Abnormal muscle fiber emerin
................... HP:0030119 Abnormal muscle fiber calpain-3
................... HP:0030122 Reduced muscle fiber perlecan
................... HP:0030123 Abnormal muscle fiber lamin A/C
................... HP:0030224 Abnormal muscle fiber desmin
................... HP:0030226 Abnormal muscle fiber myotilin
................... HP:0030228 Abnormal muscle fiber valosin-containing protein
........expandCentral core regions in muscle fibers (HP:0030230) help
........expandReduced muscle carnitine level (HP:0030362) help
........expandInternally nucleated skeletal muscle fibers (HP:0031237) help
........expandNecklace skeletal muscle fibers (HP:0031238) help
........expandMyelin-like whorls in vacuolated fibers (HP:0031542) help
........expandMuscle fiber hypertrophy (HP:0100293) help
........expandMuscle fiber atrophy (HP:0100295) help
................... HP:0003554 Type 2 muscle fiber atrophy
................... HP:0011807 Type 1 muscle fiber atrophy
........expandPerifascicular muscle fiber atrophy (HP:0100296) help
........expandIncreased endomysial connective tissue (HP:0100297) help
........expandMotheaten muscle fibers (HP:0100298) help
........expandMuscle fiber inclusion bodies (HP:0100299) help
................... HP:0025200 Muscle fiber actin filament accumulation
................... HP:0100303 Muscle fiber cytoplasmatic inclusion bodies
................... HP:0100304 Muscle fiber intranuclear inclusion bodies
........expandRing fibers (HP:0100305) help

 Sister Nodes: 
..expandAbnormality of muscle size (HP:0030236) help
..expandCalcinosis (HP:0003761) help
..expandDecreased muscle mass (HP:0003199) help
..expandFatty replacement of skeletal muscle (HP:0012548) help
..expandFirm muscles (HP:0003725) help
..expandFlexion contracture (HP:0001371) help
..expandGeneralized muscular appearance from birth (HP:0003716) help
..expandIntramuscular hematoma (HP:0012233) help
..expandLevator palpebrae superioris atrophy (HP:0012241) help
..expandMuscular dystrophy (HP:0003560) help
..expandMuscular edema (HP:0100748) help
..expandMyopathy (HP:0003198) help
..expandMyositis (HP:0100614) help
..expandRhabdomyolysis (HP:0003201) help
..expandSkeletal muscle fibrosis (HP:0030951) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0004303HP:0004303Abnormal muscle fiber morphology0CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100298Motheaten muscle fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003805Rimmed vacuoles1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100293Muscle fiber hypertrophy1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030362Reduced muscle carnitine level1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0033684Abnormal muscle fiber-type distribution1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003791Deposits immunoreactive to beta-amyloid protein1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0031542Myelin-like whorls in vacuolated fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0012269Abnormal muscle glycogen content1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003200Ragged-red muscle fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003687Centrally nucleated skeletal muscle fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003555Muscle fiber splitting1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100296Perifascicular muscle fiber atrophy1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0012084Abnormality of skeletal muscle fiber size1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030230Central core regions in muscle fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003713Muscle fiber necrosis1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0009058Increased muscle lipid content1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100295Muscle fiber atrophy1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100305Ring fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0020201Abnormal sarcomere morphology1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100299Muscle fiber inclusion bodies1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030089Abnormal muscle fiber protein expression1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003736Autophagic vacuoles1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100297Increased endomysial connective tissue1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0031238Necklace skeletal muscle fibers1CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030228Abnormal muscle fiber valosin-containing protein2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003755Type 1 fibers relatively smaller than type 2 fibers2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030103Abnormal muscle fiber beta sarcoglycan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030104Abnormal muscle fiber gamma sarcoglycan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030119Abnormal muscle fiber calpain-32CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0012240Increased intramyocellular lipid droplets2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030123Abnormal muscle fiber lamin A/C2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003554Type 2 muscle fiber atrophy2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030090Abnormal muscle fiber merosin expression2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030113Abnormal muscle fiber dysferlin2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100303Muscle fiber cytoplasmatic inclusion bodies2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003557Increased variability in muscle fiber diameter2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030122Reduced muscle fiber perlecan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0010602Type 2 muscle fiber predominance2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0009051Increased muscle glycogen content2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030105Abnormal muscle fiber delta sarcoglycan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0011807Type 1 muscle fiber atrophy2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0020202Abnormal Z disc morphology2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0025200Muscle fiber actin filament accumulation2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030226Abnormal muscle fiber myotilin2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030112Abnormal muscle fiber alpha dystroglycan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030096Abnormal muscle fiber dystrophin expression2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030095Reduced muscle collagen VI2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003803Type 1 muscle fiber predominance2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0012270Decreased muscle glycogen content2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030093Abnormal muscle fiber laminin beta 12CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030224Abnormal muscle fiber desmin2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0031237Internally nucleated skeletal muscle fibers2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030100Abnormal muscle fiber alpha sarcoglycan2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030116Abnormal muscle fiber emerin2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100304Muscle fiber intranuclear inclusion bodies2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0033685Fiber type grouping2CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030120Absent muscle fiber calpain-33CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030124Reduced muscle fiber lamin A/C3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030232Increased sarcoplasmic glycogen3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030111Reduced muscle fiber delta sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030091Absent muscle fiber merosin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0020203Z-band streaming3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030114Absent muscle fiber dysferlin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100300Desmin bodies3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030099Reduced muscle fiber alpha dystroglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030098Reduced muscle dystrophin expression3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0003798Nemaline bodies3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030231Glycogen accumulation in muscle fiber lysosomes3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030110Absent muscle fiber delta sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0033008Increased Z-disc width3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030227Accumulation of muscle fiber myotilin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030046Hypoglycosylation of alpha-dystroglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030097Absent muscle dystrophin expression3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100302Muscle fiber tubuloreticular inclusions3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030102Reduced muscle fiber alpha sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030118Reduced muscle fiber emerin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030108Reduced muscle fiber gamma sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030094Reduced muscle fiber laminin beta 13CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030225Accumulation of muscle fiber desmin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100301Muscle fiber tubular inclusions3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030101Absent muscle fiber alpha sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030117Absent muscle fiber emerin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030107Reduced muscle fiber beta sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030121Reduced muscle fiber calpain-33CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030092Reduced muscle fiber merosin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030115Reduced muscle fiber dysferlin3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0100306Muscle fiber hyaline bodies3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030229Accumulation of muscle fiber valosin-containing protein3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030106Absent muscle fiber beta sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
HP:0004303HP:0030109Absent muscle fiber gamma sarcoglycan3CAV3 CL E G H859123320Elevated serum creatine phosphokinase123320C0241005OMIM14171529601253
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0004303HP:0004303Abnormal muscle fiber morphology0GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100295Muscle fiber atrophy1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100305Ring fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0020201Abnormal sarcomere morphology1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100299Muscle fiber inclusion bodies1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030089Abnormal muscle fiber protein expression1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003736Autophagic vacuoles1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100297Increased endomysial connective tissue1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0031238Necklace skeletal muscle fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003805Rimmed vacuoles1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100293Muscle fiber hypertrophy1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030362Reduced muscle carnitine level1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0033684Abnormal muscle fiber-type distribution1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003791Deposits immunoreactive to beta-amyloid protein1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0031542Myelin-like whorls in vacuolated fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0012269Abnormal muscle glycogen content1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100298Motheaten muscle fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003687Centrally nucleated skeletal muscle fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003555Muscle fiber splitting1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003200Ragged-red muscle fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0012084Abnormality of skeletal muscle fiber size1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030230Central core regions in muscle fibers1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003713Muscle fiber necrosis1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0009058Increased muscle lipid content1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100296Perifascicular muscle fiber atrophy1GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030093Abnormal muscle fiber laminin beta 12GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030224Abnormal muscle fiber desmin2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0031237Internally nucleated skeletal muscle fibers2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030100Abnormal muscle fiber alpha sarcoglycan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030116Abnormal muscle fiber emerin2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100304Muscle fiber intranuclear inclusion bodies2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0033685Fiber type grouping2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0012270Decreased muscle glycogen content2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030228Abnormal muscle fiber valosin-containing protein2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003755Type 1 fibers relatively smaller than type 2 fibers2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030103Abnormal muscle fiber beta sarcoglycan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030104Abnormal muscle fiber gamma sarcoglycan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003554Type 2 muscle fiber atrophy2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030090Abnormal muscle fiber merosin expression2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030113Abnormal muscle fiber dysferlin2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100303Muscle fiber cytoplasmatic inclusion bodies2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003557Increased variability in muscle fiber diameter2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030122Reduced muscle fiber perlecan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0010602Type 2 muscle fiber predominance2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030119Abnormal muscle fiber calpain-32GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0012240Increased intramyocellular lipid droplets2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030123Abnormal muscle fiber lamin A/C2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030105Abnormal muscle fiber delta sarcoglycan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0011807Type 1 muscle fiber atrophy2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0020202Abnormal Z disc morphology2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0025200Muscle fiber actin filament accumulation2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030226Abnormal muscle fiber myotilin2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030112Abnormal muscle fiber alpha dystroglycan2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030096Abnormal muscle fiber dystrophin expression2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030095Reduced muscle collagen VI2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003803Type 1 muscle fiber predominance2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0009051Increased muscle glycogen content2GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030092Reduced muscle fiber merosin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030115Reduced muscle fiber dysferlin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100306Muscle fiber hyaline bodies3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030229Accumulation of muscle fiber valosin-containing protein3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030106Absent muscle fiber beta sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030109Absent muscle fiber gamma sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030121Reduced muscle fiber calpain-33GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030124Reduced muscle fiber lamin A/C3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030232Increased sarcoplasmic glycogen3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030111Reduced muscle fiber delta sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030091Absent muscle fiber merosin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0020203Z-band streaming3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030114Absent muscle fiber dysferlin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100300Desmin bodies3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030099Reduced muscle fiber alpha dystroglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030098Reduced muscle dystrophin expression3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0003798Nemaline bodies3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030120Absent muscle fiber calpain-33GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030231Glycogen accumulation in muscle fiber lysosomes3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030110Absent muscle fiber delta sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0033008Increased Z-disc width3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030227Accumulation of muscle fiber myotilin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030046Hypoglycosylation of alpha-dystroglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030097Absent muscle dystrophin expression3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100302Muscle fiber tubuloreticular inclusions3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030102Reduced muscle fiber alpha sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030118Reduced muscle fiber emerin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030094Reduced muscle fiber laminin beta 13GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030225Accumulation of muscle fiber desmin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0100301Muscle fiber tubular inclusions3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030101Absent muscle fiber alpha sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030117Absent muscle fiber emerin3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030107Reduced muscle fiber beta sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240
HP:0004303HP:0030108Reduced muscle fiber gamma sarcoglycan3GLI3 CL E G H2737175700Greig cephalopolysyndactyly syndrome175700C0265306OMIM09814319165240


Genes (209) :ABCA7 ABHD5 ACTA1 ADSSL1 AFG3L2 AGPAT2 AGRN AIFM1 AK9 ALG14 ALG2 ANO5 APP ASCC1 ATP8 BCS1L BIN1 BSCL2 BVES CACNA1S CAPN3 CASQ1 CAV1 CAV3 CAVIN1 CCDC174 CCDC78 CFL2 CHAT CHCHD10 CHRNA1 CHRNB1 CHRND CHRNE CNBP COA7 COA8 COL12A1 COL13A1 COL6A1 COL6A2 COL6A3 COLQ COQ2 COQ8A COX1 COX10 COX14 COX2 COX20 COX3 COX6B1 COX8A CPT2 CRPPA CRYAB CYTB DAG1 DGUOK DNAJB6 DNM2 DOK7 DPAGT1 DPM3 DYNC1H1 DYSF EARS2 EMD ENO3 FASTKD2 FHL1 FKRP FKTN FLNC FOS GABRA3 GFER GFPT1 GLI3 GMPPB GNE GYG1 GYS1 HACD1 HNRNPA1 HNRNPA2B1 HNRNPDL IFIH1 ISCU ITGA7 KBTBD13 KCNA1 KCNE3 KCNJ18 KLHL40 KLHL41 LAMA2 LAMB2 LDB3 LMNA LMOD3 LRP4 MAP3K20 MATR3 MGME1 MICU1 MSTO1 MTMR14 MUSK MYF6 MYH14 MYH2 MYH7 MYL2 MYO18B MYO9A MYOT MYPN ND1 ND4 ND5 ND6 NDUFB3 NEB NEFH NEFL OPA1 ORAI1 PABPN1 PET100 PFKM PHKB PNPLA2 POLG POLG2 POMT1 PPARG PSEN1 PSEN2 PYROXD1 RAPSN RNR1 RRM2B RYR1 SARS2 SCN4A SCO1 SDHA SDHAF1 SDHD SELENON SGCB SGCG SIL1 SLC18A3 SLC22A5 SLC25A1 SLC25A26 SLC25A32 SLC25A4 SLC5A7 SNAP25 SORL1 SPEG SPG7 SQSTM1 STIM1 SYNE1 SYNE2 SYT2 TACO1 TCAP TIA1 TK2 TMEM43 TNNT1 TNPO3 TNXB TOMM40 TOR1AIP1 TPM2 TPM3 TRAPPC11 TREM2 TRIM32 TRIP4 TRMU TRNC TRNE TRNF TRNH TRNI TRNK TRNL1 TRNL2 TRNN TRNP TRNQ TRNS1 TRNS2 TRNV TRNW TRPV4 TTN TWNK TYMP VAMP1 VCP VPS13A

Diseases (202) :123320 175700 1020 97240 171439 255310 616852 617030 528 98914 300816 353327 616228 206549 480 124000 169189 169186 255200 616812 618129 2593 488650 614807 457050 75840 254090 607426 550 540000 608836 399058 608810 617070 34516 603511 615368 160150 263494 612937 253601 254130 614924 98863 300696 609524 330054 602 605820 52430 615426 615424 615422 609115 182250 607855 258 609452 98853 2348 98855 617760 600 606070 352447 401768 605637 324604 437572 160500 255160 608358 266 551 616924 270 98908 610717 254886 254892 70595 157640 258450 603041 298 607459 86812 79083 597 98905 324581 252011 353 253700 248800 212140 616794 616839 609283 99013 617158 601954 604454 609560 608423 606408 617072 369840 254110 486815 617066 616866 254864 545000 1349 663 181405 178464 609 600334 611705 609286 329478 167320 2388 98907 171433 2020 171436 171430 161800 614487 98913 238329 616867 681 79102 616816 254210 608930 601462 605809 608931 602668 220110 98915 603034 612016 158600 310300 612932 300718 300717 263297 611556 255125 613204 972 502423 617675 397744 59135 98911 609200 171881 256030 125250 232800 371 261750 178145 424107 117000 255320 613845 602771 119 160565 98902 605355 609285 1878 610687 370980 352479 616052 613818 178400 34515 272 615350 615351 615352 609273 615348 616549 617336 618246 399103 607684 617258 609284
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.